2021
DOI: 10.1007/s42770-021-00492-5
|View full text |Cite
|
Sign up to set email alerts
|

Potential of 1-(1-napthylmethyl)-piperazine, an efflux pump inhibitor against cadmium-induced multidrug resistance in Salmonella enterica serovar Typhi as an adjunct to antibiotics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 39 publications
1
8
0
Order By: Relevance
“…, and Cr 2 O 7 − (Harrison et al, 2009;Kaur et al, 2021). Cd and Cu 2+ ions also act as an inducer to derepress the multiple antibiotic resistance regulatory operon marRAB in both Salmonella sp.…”
Section: Co -Regulation As a Mechanism For Co -Selectionmentioning
confidence: 99%
See 3 more Smart Citations
“…, and Cr 2 O 7 − (Harrison et al, 2009;Kaur et al, 2021). Cd and Cu 2+ ions also act as an inducer to derepress the multiple antibiotic resistance regulatory operon marRAB in both Salmonella sp.…”
Section: Co -Regulation As a Mechanism For Co -Selectionmentioning
confidence: 99%
“…Besides these co-selection strategies, combined resistance to antibiotics and metals is aided by the formation of biofilms also. The heavy metal or antibiotic stress induces the production of certain substances that aid Kaur et al (2021) in cellular adhesion along with the production of extracellular polymeric substances (EPS) in planktonic cells which subsequently helps in the formation of biofilms (Baker-Austin et al, 2006). Induction of biofilm due to production of EPS as a survival strategy on exposure to metals has been reported by García-Meza et al (2005) and Kidambi et al (1995) in Phormidium (cyanobacteria) and Pseudomonas species respectively.…”
Section: Co -Regulation As a Mechanism For Co -Selectionmentioning
confidence: 99%
See 2 more Smart Citations
“…As for Gram-positive specific antibiotics whose activity is potentiated by OM-disrupting synergists, we have chosen to focus on clinically used agents that are most commonly evaluated for synergy with OM disrupters: erythromycin, rifampicin, vancomycin, and novobiocin. , This criterion has, for example, led to the exclusion of OM-disrupting agents for which synergy was reported with macrolide antibiotics other than erythromycin. Also, while the specific media conditions used in antibacterial assays can strongly influence the outcome of synergy studies, for the sake of brevity, we do not include this level of detail here and instead provide clear referencing of the original studies wherein such information can be found. In addition, to further streamline the Review, synergists for which an OM-disrupting mechanism was not clearly demonstrated are not here discussed in detail. Furthermore, synergists that specifically engage with Gram-negative targets and subsequently cause OM disruption as a secondary effect are not discussed in this Review. …”
mentioning
confidence: 99%